Decreased transthyretin predicts a poor prognosis in primary myelodysplastic syndrome

BACKGROUND: This study aims to investigate the prognostic significance of transthyretin in newly diagnosed myelodysplastic syndromes (MDS). METHODS: The clinical, laboratory, and follow-up data of 280 newly diagnosed patients with MDS were collected. The relationship between serum transthyretin leve...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ying, Niu, Tingting, Chen, Ting, Wu, Yue, Zou, Duobing, Shi, Cong, Wu, Ying, Zhang, Zhaoyi, Wu, Ningning, Zhang, Yi, Yan, Xiao, Sheng, Lixia, Lv, Dingfeng, Ouyang, Guifang, Chen, Xueqin, Mu, Qitian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027903/
https://www.ncbi.nlm.nih.gov/pubmed/36960201
http://dx.doi.org/10.3389/fnut.2023.1125768

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10027903/
https://www.ncbi.nlm.nih.gov/pubmed/36960201
http://dx.doi.org/10.3389/fnut.2023.1125768

Ejemplares similares